---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-064804"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2026-06-03T21:00:52+00:00"
generated_at: "2026-06-03T21:09:03.160124+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026

## Summary
- Every 15 shares of common stock combined into 1 share; par value unchanged at $0.0001.
- Authorized shares reduced proportionately from 100M to approximately 6.67M.
- Fractional shares rounded up to the next whole share; no fractional shares issued.
- Common stock trades under same symbol SILO but with new CUSIP 82711P 300.
- Split-adjusted trading began on The Nasdaq Capital Market on June 3, 2026.

## SEC filing metadata
- accession: 0001213900-26-064804
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2026-06-03T21:00:52+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/0001213900-26-064804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/ea0293111-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-064804
- JSON: https://secwatch.observer/filing/0001213900-26-064804.json
- Plain text: https://secwatch.observer/filing/0001213900-26-064804.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.